Skip to main content

Joaquin Ruiz Altarejos

Joaquin Ruiz Altarejos

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Emma Granados Serra

Emma Granados Serra

Tècnic/a Grau Superior
Unitat legal
Legal Directorate
Read more
Javier Domeño Baztán

Javier Domeño Baztán

Research technician
Clinical Neuroimmunology
Read more
Jesús Quintero Bernabeu

Jesús Quintero Bernabeu

Main researcher
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Aroa  Gomez  Brey

Aroa Gomez Brey

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.